Pharmaron, Inc.

No reviews yet · Write a Review
Pharmaron is a leading life science contract research organization, dedicated to supporting the entire lifecycle of drug development from discovery through to commercialization. With a comprehensive suite of R&D and manufacturing service capabilities, we focus on small molecules, biologics, and cell and gene therapies, ensuring a streamlined path from laboratory to market. We pride ourselves on a science-driven approach, aiming to facilitate partners' success in introducing innovative medicines to improve patient outcomes. By leveraging integrated services in laboratory chemistry, manufacturing controls, clinical development, and more, Pharmaron stands as a pivotal ally in the life science sector. Our commitment to advancing medical research reflects in their mission to assist in the discovery, development, and commercialization of new, effective treatments.

Company Details

Address
201 E Jefferson St
Louisville, KY 40202

Competitors of Pharmaron, Inc.

MDI Consultants, with over 45 years of expertise, is a premier provider of FDA regulatory compliance consulting, specializing in medical device, pharmaceutical, and food industry sectors. Our comprehensive services support global companies in achieving and maintaining FDA, EU, and Health Canada... Read More

10 Products 0 White Papers 0 Press Releases

SARACA Solutions is an ISO 13485 certified medical device engineering services company delivering innovative, cost-effective solutions with a strong commitment to customer satisfaction, quality, and regulatory compliance. Our multidisciplinary team—comprising quality and regulatory engineers,... Read More

18 Products 0 White Papers 0 Press Releases

NAMSA is medical research organization providing expert regulatory, laboratory, clinical, and compliance services to medical device and healthcare product manufacturers. At every stage of the product development process, we provide strategic guidance and tactical support to help clients... Read More

10 Products 0 White Papers 0 Press Releases